Compare Align Technology, Inc. (ALGN) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs Vanguard Short Term Corporate Bond ETF — how do they compare? Align Technology, Inc. trades at $181.11 (market cap $12.86B), while Vanguard Short Term Corporate Bond ETF trades at $78.45. The key difference: Align Technology, Inc. is trading nearer its 52-week high, Vanguard Short Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| ALGN | VCSH | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Fixed Income |
52-Week High | $207.19 | $80.20 |
52-Week Low | $124.88 | $78.61 |
Enterprise Value | $11.92B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
VCSH trades at $78.61, down 0.1% with a bearish technical outlook showing 16 sell signals versus 1 buy. The ETF maintains consistent dividend distributions with recent payments of $0.29-$0.30 per share. News coverage highlights VCSH's competitive expense ratio and yield advantages over comparable short-term bond ETFs, though institutional positions show mixed adjustments.
The short-term corporate bond ETF faces headwinds from the Fed's indication of no rate cuts in 2026, potentially limiting near-term upside. Current technical weakness suggests cautious positioning, though the neutral oscillator reading and institutional interest from firms like BlueSky Wealth Advisors provide some support. The primary risk remains interest rate sensitivity in the current monetary policy environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Vanguard Short Term Corporate Bond ETF
VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.
Read more on VCSH →
